We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against the other stocks ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

Results: Nippon Life India Asset Management (NAM India) on Thursday reported a 4 per cent increase in profit after tax to Rs 295.4 crore for three months ended December 2024.

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024.

Suryoday Small Finance Bank reported a 42% YoY drop in Q3 FY25 net profit to ₹33.3 crore due to higher expenses and worsening asset quality, despite 25.8% growth in gross advances.

The microfinance institution Spandana Sphoorty Financial Ltd (SSFL) posted a significant loss of Rs 440 crore in the third ...

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a look at where The Procter & Gamble Company (NYSE:PG) stands against the ...

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a ...

The company has a market cap of Rs 1.62 lakh crore. It reported a rise of around 85 per cent in profit in Q3. Prashant Tamta Updated : Jan 23, 2025, 08:30 PM IST Another company of billionaire Gautam ...